Some studies show that proliferation marker Ki-67 correlates with significantly shorter recurrence-free survival (RFS) in meningiomas of all grades, if for example tumors have a proliferation index > 3%7 or when > 25 positive cell nuclei per square millimetre8 are observed. The gene discussed is MKI67; the disease is meningioma.